AbbVie Inc. ( ABBV) - Stock Earnings
ABBV Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 30, 2026, midnight | — / — | — | — / — | — |
ABBV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.8 billion USD | 16.6 billion USD |
| 2026Q1 | 699.0 million USD | 15.0 billion USD |
| 2026Q2 | 3.6 billion USD | 17.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ABBV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.9 billion USD | 54.3 billion USD |
| 2024 | 4.3 billion USD | 56.3 billion USD |
| 2025 | 4.2 billion USD | 61.2 billion USD |
| 2026 Est. | — | — |
ABBV
List: Contenders
Price: $276.47
Dividend Yield: 2.56%
Forward Dividend Yield: 2.50%
Payout Ratio: 207.36%
Dividend Per Share: 6.92 USD
Earnings Per Share: 3.57 USD
P/E Ratio: 68.96
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.2 million
Ebitda: 1.9 billionMarket Capitalization: 471.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 14
DGR3: 5.17%
DGR5: 6.83%
DGR10: 12.90%